- Home
- MYGN vs SAH Comparison
MYGN vs SAH Comparison
Compare MYGN & SAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYGN
- SAH
- Stock Information
- Founded
- MYGN 1991
- SAH 1997
- Country
- MYGN United States
- SAH United States
- Employees
- MYGN N/A
- SAH N/A
- Industry
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- SAH Other Specialty Stores
- Sector
- MYGN Health Care
- SAH Consumer Discretionary
- Exchange
- MYGN Nasdaq
- SAH Nasdaq
- Market Cap
- MYGN 744.7M
- SAH 2.7B
- IPO Year
- MYGN 1995
- SAH 1997
- Fundamental
- Price
- MYGN $5.34
- SAH $87.38
- Analyst Decision
- MYGN Hold
- SAH Strong Buy
- Analyst Count
- MYGN 15
- SAH 8
- Target Price
- MYGN $15.14
- SAH $74.63
- AVG Volume (30 Days)
- MYGN 1.3M
- SAH 202.0K
- Earning Date
- MYGN 08-05-2025
- SAH 07-24-2025
- Dividend Yield
- MYGN N/A
- SAH 1.61%
- EPS Growth
- MYGN N/A
- SAH 43.80
- EPS
- MYGN N/A
- SAH 7.02
- Revenue
- MYGN $831,300,000.00
- SAH $14,491,600,000.00
- Revenue This Year
- MYGN N/A
- SAH $4.55
- Revenue Next Year
- MYGN $6.68
- SAH $3.44
- P/E Ratio
- MYGN N/A
- SAH $12.43
- Revenue Growth
- MYGN 7.38
- SAH 1.59
- 52 Week Low
- MYGN $3.81
- SAH $51.29
- 52 Week High
- MYGN $29.30
- SAH $89.62
- Technical
- Relative Strength Index (RSI)
- MYGN 50.85
- SAH 76.15
- Support Level
- MYGN $4.90
- SAH $85.50
- Resistance Level
- MYGN $5.83
- SAH $89.62
- Average True Range (ATR)
- MYGN 0.28
- SAH 2.42
- MACD
- MYGN 0.04
- SAH 0.20
- Stochastic Oscillator
- MYGN 54.21
- SAH 80.94
About MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.
About SAH Sonic Automotive Inc.
Sonic Automotive is one of the largest auto dealership groups in the United States. The company has 108 franchised stores in 18 states, primarily in metropolitan areas in California, Texas, and the Southeast, plus 18 EchoPark used-vehicle stores, 16 collision centers, and 15 powersports locations. The franchise stores derive revenue from new and used vehicles plus parts and collision repair, finance, insurance, and wholesale auctions. Luxury and import dealerships make up about 86% of franchise new-vehicle revenue, while Honda, BMW, Mercedes, and Toyota constitute about 59% of new-vehicle revenue. BMW is the largest brand at about 25%. 2024's revenue was $14.2 billion, with Texas and California comprising 51% of the total. EchoPark's portion was $2.1 billion.